Companies: 10,795·Total market cap: $144.5T
Deep Medicine Acquisition Corp.

Deep Medicine Acquisition Corp.

DMAQNASDAQFinancial Services
$2.96
$-5.43(-64.72%)
Market Cap$12899562
P/E Ratio
52W High$19.91
52W Low$2.96

Deep Medicine Acquisition Corp.(DMAQ)· 损益表

年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q(经 FMP 聚合)· 可在下方切换周期与 M/B/T 单位。

FMP · DMAQ · 截至 2026-06-09

财务报表

Revenue · Gross Profit · Net Income
Breakdown2026-032025-032023-032022-03
Revenue
Revenue$18.88M$21.86M$0.00M$0.00M
Cost of Revenue$9.36M$7.27M$0.06M$0.06M
Gross Profit$9.52M$14.59M($0.06M)($0.06M)
Gross Margin %(computed)50.42%66.73%
Operating Expenses
R&D Expenses$0.00M$0.00M$0.00M$0.00M
G&A Expenses$0.00M$0.00M$1.91M$0.41M
Total Operating Expenses$11.01M$9.42M$2.11M$0.41M
Operating Income($6.10M)($2.10M)($0.34M)($0.46M)
Operating Margin %(computed)-32.32%-9.62%
Interest Income$0.27M$0.11M$0.00M$0.00M
Interest Expense($3.26M)($6.93M)$0.00M$0.01M
Income Before Tax($15.23M)($8.80M)($0.34M)($0.41M)
Income Tax Expense$0.00M$0.00M$0.06M($0.06M)
Net Income($15.23M)($8.80M)($0.40M)($0.36M)
Net Margin %(computed)-80.66%-40.24%
Per Share & EBITDA
EPS (Basic)$-51.39$-756.01$-0.17$-0.04
Wtd Avg Shares0.30M11.63M2.31M8.74M
EBITDA($6.10M)($2.10M)($3.99M)($0.35M)
EBITDA Margin %(computed)-32.32%-9.62%

数据来源:Financial Modeling Prep · 最后更新:2026-06-09 · USD · M

深入了解Deep Medicine Acquisition Corp.

关于Deep Medicine Acquisition Corp.(DMAQ)损益表

Deep Medicine Acquisition Corp.(DMAQ)损益表数据来源于SEC Form 10-K及10-Q申报文件。2026财年,DMAQ实现营收$0.02B,毛利润$0.01B(毛利率50.42%),净利润($0.02B)(净利率-80.66%)。

常见问题

DMAQ · 4 问

Deep Medicine Acquisition Corp.(DMAQ)2026财年营收为$0.02B,同比down13.6%。

DMAQ revenueDMAQ salesannual revenue YoYincome statement

· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09